Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neus Villamor

Showing results (101-110 of 136) with videos related to

Pageof 14
Sort By:
Oncotarget|December 25, 2015
CD69 expression potentially predicts response to bendamustine and its modulation by ibrutinib or idelalisib enhances cytotoxic effect in chronic lymphocytic leukemiaArnau Montraveta, Eriong Lee-Vergés, Jocabed Roldán, et al.
Cancers|December 1, 2020
<i>STAT3</i> and <i>STAT5B</i> Mutations in T/NK-Cell Chronic Lymphoproliferative Disorders of Large Granular Lymphocytes (LGL): Association with Disease FeaturesNoemí Muñoz-García, María Jara-Acevedo, Carolina Caldas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2016
The Human CD38 Monoclonal Antibody Daratumumab Shows Antitumor Activity and Hampers Leukemia-Microenvironment Interactions in Chronic Lymphocytic LeukemiaAlba Matas-Céspedes, Anna Vidal-Crespo, Vanina Rodriguez, et al.
The American Journal of Surgical Pathology|July 15, 2011
Nonhepatosplenic γδ T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentationAdriana Garcia-Herrera, Joo Y Song, Shih-Sung Chuang, et al.
Oncogene|October 17, 2019
Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cellsMónica López-Guerra, Sílvia Xargay-Torrent, Patricia Fuentes, et al.
British Journal of Haematology|November 17, 2020
Baseline correlations and prognostic impact of serum monoclonal proteins in follicular lymphomaPablo Mozas, Andrea Rivero, Alfredo Rivas-Delgado, et al.
Frontiers in Oncology|February 17, 2022
Results of ARI-0001 CART19 Cells in Patients With Chronic Lymphocytic Leukemia and Richter's TransformationValentín Ortiz-Maldonado, Gerard Frigola, Marta Español-Rego, et al.
Blood|October 15, 2013
Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemiaPau Abrisqueta, Neus Villamor, María José Terol, et al.
Nature|September 10, 2025
Fluctuating DNA methylation tracks cancer evolution at clinical scaleCalum Gabbutt, Martí Duran-Ferrer, Heather E Grant, et al.
Hematological Oncology|November 9, 2023
A low total metabolic tumor volume independently predicts for a longer time to first treatment in initially observed, low tumor burden follicular lymphomaPablo Mozas, Sebastian Casanueva-Eliceiry, Andrea Rivero, et al.
Pageof 14

Showing results (101-110 of 136) with videos related to

Sort By:
Pageof 14
Oncotarget|December 25, 2015
CD69 expression potentially predicts response to bendamustine and its modulation by ibrutinib or idelalisib enhances cytotoxic effect in chronic lymphocytic leukemiaArnau Montraveta, Eriong Lee-Vergés, Jocabed Roldán, et al.
Cancers|December 1, 2020
<i>STAT3</i> and <i>STAT5B</i> Mutations in T/NK-Cell Chronic Lymphoproliferative Disorders of Large Granular Lymphocytes (LGL): Association with Disease FeaturesNoemí Muñoz-García, María Jara-Acevedo, Carolina Caldas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2016
The Human CD38 Monoclonal Antibody Daratumumab Shows Antitumor Activity and Hampers Leukemia-Microenvironment Interactions in Chronic Lymphocytic LeukemiaAlba Matas-Céspedes, Anna Vidal-Crespo, Vanina Rodriguez, et al.
The American Journal of Surgical Pathology|July 15, 2011
Nonhepatosplenic γδ T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentationAdriana Garcia-Herrera, Joo Y Song, Shih-Sung Chuang, et al.
Oncogene|October 17, 2019
Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cellsMónica López-Guerra, Sílvia Xargay-Torrent, Patricia Fuentes, et al.
British Journal of Haematology|November 17, 2020
Baseline correlations and prognostic impact of serum monoclonal proteins in follicular lymphomaPablo Mozas, Andrea Rivero, Alfredo Rivas-Delgado, et al.
Frontiers in Oncology|February 17, 2022
Results of ARI-0001 CART19 Cells in Patients With Chronic Lymphocytic Leukemia and Richter's TransformationValentín Ortiz-Maldonado, Gerard Frigola, Marta Español-Rego, et al.
Blood|October 15, 2013
Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemiaPau Abrisqueta, Neus Villamor, María José Terol, et al.
Nature|September 10, 2025
Fluctuating DNA methylation tracks cancer evolution at clinical scaleCalum Gabbutt, Martí Duran-Ferrer, Heather E Grant, et al.
Hematological Oncology|November 9, 2023
A low total metabolic tumor volume independently predicts for a longer time to first treatment in initially observed, low tumor burden follicular lymphomaPablo Mozas, Sebastian Casanueva-Eliceiry, Andrea Rivero, et al.
Pageof 14